Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRMT2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
C14orf166 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KCNJ4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DUS4L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KLRC4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
HDAC11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ABO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EML2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EBLN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMCO1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OGFR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFT74 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RFPL3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SGPL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RFPL3S - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CADM3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on